.jpg)
Associate Professor
Children's Mercy - Kansas City/University of Missouri - Kansas City
Kansas City, Missouri, United States
Matt McLaughlin is a Pediatric Rehabilitation Medicine physician and Clinical Pharmacologist. His primary research centers on optimizing “the right medication for the right patient at the right time to improve outcomes.” He completed the MD/BA 6-year program at the University of Missouri-Kansas City prior to starting his fellowship at the University of Missouri-Columbia. After graduation from residency, he pursued a clinical Pediatric Rehabilitation Medicine fellowship at Children’s Mercy Hospital in Kansas City. During this time, he obtained his Masters in Medical Bioinformatics to help with clinical research design and database management. Upon graduation, he was named a Vice Chancellors Honors Recipient for obtaining a 4.0 GPA while also positively contributing to the Kansas City community. He received advance training in Clinical Pharmacology by participating in an NICHD T32 Fellowship in Pediatric Clinical and Developmental Pharmacology prior to starting his NIH K12 funding.
Dr. McLaughlin’s primary research work has centered around precision medicine in pediatric patients with cerebral palsy (CP). Clinically, he remains passionate about how to employ the pharmacogenetics associated with alterations in medication absorption, distribution, elimination and metabolism with improving clinical outcomes. He employs aspects of pharmacokinetic modeling, pharmacogenomics and clinical trial design in his studies. His work earned him the Best Original Research Article by a Young Physician by the PM&R Journal in 2018. He is currently an Associate Professor in the Department of Pediatrics at Children’s Mercy – Kansas City.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Wednesday, November 9, 2022
4:45 PM – 6:00 PM
